Gennao Bio
John Heyburn has an extensive background in clinical operations and program management, with experience working in various leadership positions in the biotechnology and pharmaceutical industry. John currently holds the position of Senior Vice President at Gennao Bio, where John oversees program management. Prior to this, John held roles at Tmunity Therapeutics Incorporated, Advaxis, Inc., Morphotek, Inc., The Medicines Company, and PRA International, showcasing their progression and expertise in the field. John Heyburn holds a Bachelor of Arts in Neuroscience from Rutgers University and a Master of Business Administration from Rider University.
This person is not in any teams
This person is not in any offices
Gennao Bio
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.